RBC flags AstraZeneca-Daiichi lung-cancer drug data as promising
RBC Capital Markets said AstraZeneca and Daiichi Sankyo’s Enhertu showed strong late-stage lung-cancer results, but noted competition ahead in a research note.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.